Search Results

1,867 Results for "wuxi nextcode".

Sort By

Manufacturing

Merck Snaps Up WuXi Biologics Facility in Ireland for $500M

The acquisition from Wuxi Biologics, the embattled CDMO named in the BIOSECURE Act, marks another expansion of Merck’s manufacturing operations in Ireland.

January 6, 2025
·
1 min read
·
Annalee Armstrong
BIOSECURE Act

WuXi Mulls Sale of Some US, European Operations: FT

The Financial Times reported Thursday that WuXi AppTec is looking to sell its cell and gene therapy manufacturing unit, with facilities in Philadelphia, while WuXi Biologics wants to offload some of its production sites in Europe.

October 3, 2024
·
2 min read
·
Tristan Manalac
BIOSECURE Act

WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow

WuXi AppTec looks to unload its Philadelphia manufacturing sites and WuXi Biologics slows its rapid expansion in the U.S. as the companies await the Senate’s review of the BIOSECURE Act that threatens to cut them off from U.S. biopharma.

October 8, 2024
·
5 min read
·
Ben Hargreaves
Press Releases

WuXi Biologics Completes First Commercial PPQ Campaign at 15,000L Production Line in Hangzhou Site

April 18, 2025
·
3 min read
Press Releases

WuXi Biologics Again Passed GMP Inspection by Japan PMDA

February 27, 2025
·
2 min read
Press Releases

WuXi Biologics Reports Solid 2024 Annual Results and Expects Accelerated Growth in 2025

March 25, 2025
·
14 min read
Podcast

BioSpace at Meeting on the Mesa, WuXi Considers Selling U.S. Facilities, Big Pharma Layoffs, More

Cell and gene therapy investment rebounds; WuXi Biologics and other companies named in BIOSECURE Act mull options; Bayer, J&J and Pfizer’s recent layoffs; updates from the weight loss space.

October 9, 2024
·
1 min read
·
Heather McKenzie
Press Releases

NAMSA Completes Acquisition of WuXi AppTec US Medical Device Testing Business

March 4, 2025
·
2 min read
Press Releases

Insights from Chris Chen, the CEO of WuXi Biologics: How Quality Assurance and Technology Has Evolved in the Biopharmaceutical CDMO Industry

April 9, 2025
·
1 min read
China

WuXi Biologics Takes Net Profit Hit Despite Inking Record Number of New Projects

With the potential passage of the BIOSECURE Act looming, WuXi Biologics reported a 24% drop in net profit in the first half of 2024.

August 22, 2024
·
2 min read
·
Tristan Manalac